文献速递传染病防控与疫情报告免疫规划

EVA71与CVA16联合免疫诱导广谱强效抗四价EV-A IgM抗体

A broad and potent IgM antibody against tetra-EV-As induced by EVA71 and CVA16 co-immunization.
PubMed 文献 · Vaccine · 2021-09-29

研究通过EVA71与CVA16联合免疫及杂交瘤技术制备单克隆抗体,筛选出IgM型M20及IgG型B1、C31。三者均与四价肠道病毒A组交叉反应,但M20体外中和能力更强且更广,并在口服感染四价EV-A小鼠中提供交叉抗病毒保护。M20结合四价EV-A VP1 GH环内保守中和表位,有望成为EV-A预防和治疗候选抗体。

要点

  • EVA71与CVA16联合免疫可诱导针对四价EV-A的交叉反应单克隆抗体。
  • IgM型M20对四价EV-A的中和能力优于IgG型B1和C31。
  • M20靶向四价EV-A VP1 GH环保守中和表位,具预防治疗潜力。

核心结论

  • M20对四价EV-A表现出强效广谱抗病毒活性,有望成为EV-A预防和治疗候选抗体。

研究设计与样本

  • 通过EVA71与CVA16联合免疫及杂交瘤技术制备单克隆抗体,并在体外和小鼠体内分析其特性与中和能力。

主要发现

  • 筛选出IgM抗体M20及IgG抗体B1、C31,三者均与四价EV-A交叉反应。
  • M20对四价EV-A的中和能力比B1和C31更强、更广。
  • M20在口服感染四价EV-A的小鼠中提供交叉抗病毒保护。
  • M20结合四价EV-A VP1 GH环内的保守中和表位。

临床怎么用

  • M20可作为EV-A感染的预防和治疗候选抗体进一步开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the potent and broad neutralizing monoclonal antibody (mAb) against enterovirus A (EV-A) in vitro and in vivo induced by enterovirus A71(EVA71) and coxsackievirus 16 (CVA16) co-immunization. METHODS: The mAb was Generated by co-immunization with EVA71 and CVA16 through hybridomas technology. The characteristics and neutralizing ability of mAb were analysed in vitro and in mice. RESULTS: We screened three mAb, the IgM antibody M20 and IgG antibody B1 and C31. All three antibodies showed cross-reactivity against tetra-EV-As. However, M20 showed potent and broad neutralizing ability against tetra-EV-As than B1 and C31. Meanwhile, M20 provided cross-antiviral efficacy in tetra-EV-As orally infected mice. Moreover, M20 binds to a conserved neutralizing epitope within the GH loop of tetra-EV-As VP1. CONCLUSIONS: M20 and its property exhibited potent and broad antiviral activity against tetra-EV-As, and that is expected to be a potential preventive and therapeutic candidate against EV-As.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zhu W, Liu Z, Zheng X, et al. A broad and potent IgM antibody against tetra-EV-As induced by EVA71 and CVA16 co-immunization. Vaccine. 2021. PMID: 34600750. doi:10.1016/j.vaccine.2021.09.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。